Wealth Enhancement Advisory Services, LLC Vir Biotechnology, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 15,993 shares of VIR stock, worth $100,276. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,993
Previous 11,962
33.7%
Holding current value
$100,276
Previous $77,000
3.9%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
246Shares Held
109MCall Options Held
350KPut Options Held
150K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$105 Million0.67% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$82.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$81 Million34.47% of portfolio
-
State Street Corp Boston, MA5.25MShares$32.9 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $832M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...